BG
Cyclacel Pharmaceuticals, Inc.
BGMSNASDAQHealthcare·US · USD
$0.72
+0.12 (+20.00%)
Live · 2026-06-29Key statistics
Valuation
Market cap3.32M USD
Enterprise value-21.81K USD
Trailing P/E0.12
Forward P/E0.00
PEG ratio-0.00
Price / sales2.18
Price / book0.49
Profitability
Gross margin18.38%
Operating margin-31.62%
Profit margin-204.20%
Return on assets-49.33%
Return on equity20.59%
Income (TTM)
Revenue1.52M USD
Gross profit-530.00K USD
EBITDA-4.45M USD
Net income-10.10M USD
Diluted EPS$5.03
Rev. growth (YoY)16.82%
Balance sheet
Total cash3.34M USD
Total debt0.00 USD
Debt / equity0.00
Current ratio7.06
Book value / share$1.24
Cash flow (TTM)
Operating cash flow-1.80M USD
Levered free cash flow-4.00M USD
Shares & price
Shares outstanding5.52M
Float3.46M
Held by institutions1.79%
Beta-0.38
50-day MA$0.96
200-day MA$1.74
52-week high$19.87
52-week low$0.57
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Recent payments
- 2025-04-29$8,640.00
About Cyclacel Pharmaceuticals, Inc.
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Sing Ee Wong
- Headquarters
- Kuala Lumpur, Malaysia
- Website
- bgmsglobal.com